COCCIOLONE, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 493
EU - Europa 403
AS - Asia 192
SA - Sud America 4
OC - Oceania 3
Totale 1.095
Nazione #
US - Stati Uniti d'America 490
IE - Irlanda 97
IT - Italia 97
CN - Cina 88
SE - Svezia 57
DE - Germania 52
SG - Singapore 44
TR - Turchia 39
UA - Ucraina 26
GB - Regno Unito 19
FI - Finlandia 17
CZ - Repubblica Ceca 13
VN - Vietnam 10
RU - Federazione Russa 7
FR - Francia 6
IN - India 6
TH - Thailandia 4
AU - Australia 3
CA - Canada 3
BE - Belgio 2
PT - Portogallo 2
RO - Romania 2
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GR - Grecia 1
ID - Indonesia 1
MC - Monaco 1
PE - Perù 1
PL - Polonia 1
RS - Serbia 1
Totale 1.095
Città #
Chandler 108
Dublin 97
Jacksonville 96
Singapore 40
Boardman 32
Wilmington 29
Izmir 22
Nanjing 22
L'aquila 17
Ashburn 16
New York 14
Santa Clara 14
Bremen 13
Brno 13
Lawrence 13
Princeton 13
Beijing 11
Monza 9
Munich 9
Dong Ket 8
Houston 8
Milan 8
Redwood City 8
Shenyang 8
Ann Arbor 7
Helsinki 7
Rome 7
San Mateo 7
Berlin 6
Falls Church 6
Dallas 5
Hebei 5
Jinan 5
Woodbridge 5
Aquila 4
Pescara 4
Dearborn 3
Guangzhou 3
Kunming 3
London 3
Mountain View 3
Nanchang 3
Shanghai 3
Songkhla 3
Sydney 3
Tianjin 3
Brussels 2
Bucharest 2
Columbia 2
Espoo 2
Hanoi 2
Moscow 2
Pune 2
Seattle 2
Taizhou 2
Verona 2
Antalya 1
Arielli 1
Arzignano 1
Athens 1
Bangkok 1
Belluno 1
Fremont 1
Grafing 1
Haikou 1
Hefei 1
Istanbul 1
Jiaxing 1
Katowice 1
Kazan 1
Lappeenranta 1
Lima 1
Los Angeles 1
L’Aquila 1
Monaco 1
Norwalk 1
Onalaska 1
Palermo 1
Poli 1
Qingdao 1
Red Deer 1
Saint Petersburg 1
San Francisco 1
Stockholm 1
Tallinn 1
Tappahannock 1
Toronto 1
Washington 1
Yekaterinburg 1
Zhengzhou 1
Épinay-sous-sénart 1
Totale 781
Nome #
Breast cancer and psychological resilience among young women 203
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 107
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 102
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 101
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 94
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 85
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 85
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 81
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 70
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 55
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 53
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 51
Looking for a place for dose-dense TMZ regimens in GBM patients: An experience with MGMT exploratory evaluation 47
Totale 1.134
Categoria #
all - tutte 4.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202087 0 0 0 0 0 12 32 8 18 2 2 13
2020/2021160 1 14 1 15 17 7 16 12 20 8 23 26
2021/202297 6 1 27 8 6 4 3 7 6 0 5 24
2022/2023293 13 28 2 46 33 25 0 16 120 1 5 4
2023/2024103 6 3 1 4 10 29 0 4 0 10 11 25
2024/2025107 11 15 29 26 24 2 0 0 0 0 0 0
Totale 1.134